Drugs

After 175 years, the medical art with a strange and dark history is getting a lot more precise.

We ask the experts what’s coming in the next 12 months.

Combining these two technologies can make CAR T cell therapy effective, accessible, and affordable for heart disease and cancer.

Growing interest in psychedelic therapy reveals two different visions of the future: one of spiritual interconnectedness and one of sober neurochemistry.

A sugar pill could reduce the risk of deadly pain killer addiction.

From ephemeral tattoos to vagus nerve oil to a grape-waste backpack, these biotech-inspired gifts will be sure to delight and inspire.

The technique of targeting bacteria with viruses that destroy them is making a comeback, and it could help in the battle against antibiotic resistance.

Open-label placebos may defy logic, but scientists explore promising new treatment possibilities.

Senolytics that target age-related “zombie” cells could be game-changing for extending lifespans and enabling long-haul space travel.

An entrepreneur with his own rare disease finds a way to align incentives and needs to support research on rare diseases.